| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DNLI | Denali Therapeutics Inc. | Tessier-Lavigne Marc | Director | Nov 23, 2022 | Sale | $30.48 | 20,000 | 609,600 | 1,870,356 | Nov 28, 2022, 07:30 PM | |
| DNLI | Denali Therapeutics Inc. | Tessier-Lavigne Marc | Director | Nov 01, 2022 | Sale | $30.20 | 8,748 | 264,190 | 1,901,608 | Nov 03, 2022, 05:37 PM | |
| DNLI | Denali Therapeutics Inc. | Tessier-Lavigne Marc | Director | Nov 02, 2022 | Sale | $30.33 | 11,252 | 341,273 | 1,890,356 | Nov 03, 2022, 05:37 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Tessier-Lavigne Marc | Director | Oct 03, 2022 | Option Exercise | $565.66 | 7,224 | 4,086,364 | 5,881 | Oct 03, 2022, 04:05 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Tessier-Lavigne Marc | Director | Sep 29, 2022 | Option Exercise | $552.20 | 7,596 | 4,194,511 | 6,067 | Oct 03, 2022, 04:05 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Tessier-Lavigne Marc | Director | Sep 30, 2022 | Option Exercise | $555.66 | 6,856 | 3,809,639 | 5,697 | Oct 03, 2022, 04:05 PM | |
| DNLI | Denali Therapeutics Inc. | Tessier-Lavigne Marc | Director | Sep 28, 2022 | Sale | $30.82 | 20,000 | 616,304 | 1,914,779 | Sep 30, 2022, 04:50 PM | |
| DNLI | Denali Therapeutics Inc. | Tessier-Lavigne Marc | Director | Aug 23, 2022 | Sale | $31.61 | 20,000 | 632,282 | 1,930,456 | Aug 25, 2022, 06:11 PM | |
| DNLI | Denali Therapeutics Inc. | Tessier-Lavigne Marc | Director | Jul 25, 2022 | Sale | $35.61 | 20,000 | 712,110 | 1,950,556 | Jul 27, 2022, 06:49 PM | |
| DNLI | Denali Therapeutics Inc. | Tessier-Lavigne Marc | Director | Mar 23, 2022 | Sale | $33.83 | 20,000 | 676,583 | 2,035,968 | Jun 28, 2022, 03:07 PM | |
| DNLI | Denali Therapeutics Inc. | Tessier-Lavigne Marc | Director | Jun 23, 2022 | Option Exercise | $31.10 | 13,250 | 412,076 | 2,017,106 | Jun 27, 2022, 08:54 PM | |
| DNLI | Denali Therapeutics Inc. | Tessier-Lavigne Marc | Director | Jun 24, 2022 | Option Exercise | $30.61 | 46,750 | 1,430,968 | 1,977,122 | Jun 27, 2022, 08:54 PM | |
| DNLI | Denali Therapeutics Inc. | Tessier-Lavigne Marc | Director | Mar 23, 2022 | Sale | $33.83 | 20,000 | 676,583 | 2,035,968 | Mar 25, 2022, 05:57 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Tessier-Lavigne Marc | Director | Mar 21, 2022 | Option Exercise | $535.48 | 14,878 | 7,966,797 | 9,708 | Mar 23, 2022, 04:01 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Tessier-Lavigne Marc | Director | Mar 17, 2022 | Sale | $528.35 | 15,660 | 8,273,883 | 10,099 | Mar 18, 2022, 04:05 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Tessier-Lavigne Marc | Director | Mar 16, 2022 | Sale | $524.56 | 8,722 | 4,575,212 | 6,630 | Mar 18, 2022, 04:05 PM | |
| DNLI | Denali Therapeutics Inc. | Tessier-Lavigne Marc | Director | Dec 29, 2021 | Sale | $43.88 | 10,704 | 469,692 | 85,650 | Dec 30, 2021, 09:59 PM | |
| DNLI | Denali Therapeutics Inc. | Tessier-Lavigne Marc | Director | Dec 28, 2021 | Sale | $44.37 | 3,732 | 165,589 | 96,268 | Dec 30, 2021, 09:59 PM | |
| DNLI | Denali Therapeutics Inc. | Tessier-Lavigne Marc | Director | Dec 30, 2021 | Sale | $45.36 | 6,720 | 304,827 | 82,225 | Dec 30, 2021, 09:59 PM | |
| DNLI | Denali Therapeutics Inc. | Tessier-Lavigne Marc | Director | Dec 28, 2021 | Sale | $44.38 | 3,602 | 159,857 | 96,398 | Dec 30, 2021, 09:59 PM | |
| DNLI | Denali Therapeutics Inc. | Tessier-Lavigne Marc | Director | Dec 30, 2021 | Sale | $45.37 | 6,525 | 296,008 | 80,073 | Dec 30, 2021, 09:59 PM | |
| DNLI | Denali Therapeutics Inc. | Tessier-Lavigne Marc | Director | Dec 28, 2021 | Sale | $44.37 | 3,646 | 161,773 | 96,354 | Dec 30, 2021, 09:59 PM | |
| DNLI | Denali Therapeutics Inc. | Tessier-Lavigne Marc | Director | Dec 30, 2021 | Sale | $45.36 | 6,802 | 308,527 | 79,648 | Dec 30, 2021, 09:59 PM | |
| DNLI | Denali Therapeutics Inc. | Tessier-Lavigne Marc | Director | Dec 29, 2021 | Sale | $43.88 | 10,700 | 469,516 | 85,568 | Dec 30, 2021, 09:59 PM | |
| DNLI | Denali Therapeutics Inc. | Tessier-Lavigne Marc | Director | Dec 29, 2021 | Sale | $43.87 | 10,700 | 469,409 | 85,698 | Dec 30, 2021, 09:59 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Tessier-Lavigne Marc | Director | Dec 09, 2021 | Option Exercise | $518.20 | 7,568 | 3,921,738 | 5,862 | Dec 10, 2021, 05:41 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Tessier-Lavigne Marc | Director | Sep 13, 2021 | Sale | $457.69 | 25,500 | 11,671,120 | 14,828 | Sep 15, 2021, 04:02 PM | |
| DNLI | Denali Therapeutics Inc. | Tessier-Lavigne Marc | Director | Jun 07, 2021 | Sale | $44.53 | 188,756 | 8,404,798 | 2,638,748 | Jun 08, 2021, 05:10 PM | |
| DNLI | Denali Therapeutics Inc. | Tessier-Lavigne Marc | Director | May 21, 2021 | Sale | $60.13 | 37,957 | 2,282,468 | 2,551,102 | May 24, 2021, 08:05 PM | |
| DNLI | Denali Therapeutics Inc. | Tessier-Lavigne Marc | Director | May 24, 2021 | Sale | $60.03 | 8,806 | 528,580 | 2,542,296 | May 24, 2021, 08:05 PM | |
| DNLI | Denali Therapeutics Inc. | Tessier-Lavigne Marc | Director | Mar 01, 2021 | Sale | $66.22 | 100,000 | 6,622,207 | 2,723,526 | Mar 03, 2021, 04:20 PM | |
| DNLI | Denali Therapeutics Inc. | Tessier-Lavigne Marc | Director | Jun 16, 2020 | Sale | $26.10 | 400,000 | 10,440,000 | 2,739,043 | Jun 18, 2020, 09:41 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Tessier-Lavigne Marc | Director | May 06, 2020 | Sale | $370.89 | 30,000 | 11,126,796 | 16,830 | May 08, 2020, 04:03 PM | |
| REGN | REGENERON PHARMACEUTICALS, INC. | Tessier-Lavigne Marc | Director | Feb 13, 2020 | Sale | $226.54 | 28,558 | 6,469,655 | 11,109 | Feb 14, 2020, 04:10 PM | |
| REGN | REGENERON PHARMACEUTICALS INC | Tessier-Lavigne Marc | Director | Aug 05, 2015 | Sale | $323.68 | 10,000 | 3,236,825 | 6,187 | Aug 05, 2015, 08:55 PM | |
| REGN | REGENERON PHARMACEUTICALS INC | Tessier-Lavigne Marc | Director | Feb 26, 2015 | Sale | $236.43 | 6,000 | 1,418,594 | 4,187 | Feb 27, 2015, 04:32 PM | |
| REGN | REGENERON PHARMACEUTICALS INC | Tessier-Lavigne Marc | Director | Aug 26, 2014 | Option Exercise | $88.81 | 1,587 | 140,936 | 1,387 | Aug 27, 2014, 05:02 PM | |
| REGN | REGENERON PHARMACEUTICALS INC | Tessier-Lavigne Marc | Director | Aug 27, 2014 | Option Exercise | $201.56 | 6,000 | 1,209,330 | 4,187 | Aug 27, 2014, 05:02 PM | |
| AGIO | AGIOS PHARMACEUTICALS INC | Tessier-Lavigne Marc | Director | Jul 24, 2013 | Buy | $18.00 | 55,555 | 999,990 | 101,009 | Apr 03, 2014, 05:43 PM | |
| REGN | REGENERON PHARMACEUTICALS INC | Tessier-Lavigne Marc | Director | May 06, 2013 | Option Exercise | $157.07 | 26,668 | 4,188,776 | 8,334 | May 08, 2013, 05:52 PM |
Menu